Expert Opinion on Therapeutic Targets
Last updated ISSN 1472-8222
Expert Opinion on Therapeutic Targets is published by Taylor & Francis in medicine. It is a subscription journal. Its article processing charge is not published.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Expert Opinion on Therapeutic Targets is — and show you journals like it.
What it publishes
Recent work in Expert Opinion on Therapeutic Targets concentrates on these topics, taken from its published record rather than from its own description:
- Cytokine Signaling Pathways and Interactions
- MicroRNA in disease regulation
- PI3K/AKT/mTOR signaling in cancer
- Peptidase Inhibition and Analysis
- Ion channel regulation and function
- Epigenetics and DNA Methylation
- Cell death mechanisms and regulation
- Histone Deacetylase Inhibitors Research
- Angiogenesis and VEGF in Cancer
- Protein Kinase Regulation and GTPase Signaling
Key facts
| Publisher | Taylor & Francis |
|---|---|
| ISSN | 1472-8222, 1744-7631 |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | Not published |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 2,702 |
| Publishing since | 1950 |
| Journal website | informahealthcare.com/loi/ett |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Expert Opinion on Therapeutic Targets
Other established journals in medicine, if this one is not the right home for your paper: